BIOHIT HealthCare Ltd, based in North West England, is the UK subsidiary of BIOHIT OYJ, a Finnish biotechnology company specialising in the development, manufacture and marketing of products and analysis systems for the early diagnosis and prevention of gastrointestinal diseases.
We offer a portfolio of unique and patented tests designed to transform clinical practice by making screening, diagnosis and monitoring of gastrointestinal diseases more efficient and cost effective. Non-invasive diagnostics are at the core of our offering, making BIOHIT HealthCare the provider of choice for leading gastroenterologists, ENT specialists and laboratory scientists across the UK.
One key area of focus is dyspepsia and reflux. BIOHIT HealthCare are the exclusive UK distributors of PEPTEST®, a rapid immunological test for the quantitative analysis of pepsin.
PEPTEST is an innovative, non-invasive diagnostic test to help identify reflux, and is especially critical in detecting silent reflux. Based on quantitative lateral flow technology, PEPTEST detects the presence of pepsin in clinical samples from the upper digestive and respiratory tracts.
PEPTEST can be used to help diagnose and direct a wide spectrum of pathological conditions, including GORD (gastroesophageal reflux), LPR (laryngopharyngeal reflux), chronic cough, cystic fibrosis, post-lung transplant rejection, asthma and sinusitis.
Visit biohithealthcare.co.uk for more information.
Delivering excellence for over 20 years, Neomed UK is a reputable figure across a legion of esteemed medical organisations nationwide.
Providing leading laser devices and systems covering a range of applications in ENT, Dermatology and Gynaecology, Neomed UK offers training, service and accessories to ensure our clientele a safe and efficient practice.